PDT Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-39,546
Closed -$135K 746
2024
Q3
$135K Sell
39,546
-206,991
-84% -$706K 0.01% 680
2024
Q2
$1.15M Buy
246,537
+196,041
+388% +$916K 0.11% 307
2024
Q1
$375K Buy
+50,496
New +$375K 0.04% 500
2023
Q4
Sell
-156,515
Closed -$1.22M 571
2023
Q3
$1.22M Buy
156,515
+74,374
+91% +$580K 0.15% 230
2023
Q2
$676K Buy
82,141
+50,743
+162% +$418K 0.09% 331
2023
Q1
$228K Sell
31,398
-78,202
-71% -$567K 0.03% 493
2022
Q4
$972K Sell
109,600
-15,158
-12% -$134K 0.16% 231
2022
Q3
$1.53M Buy
124,758
+37,793
+43% +$463K 0.23% 111
2022
Q2
$1.03M Buy
86,965
+28,764
+49% +$340K 0.09% 387
2022
Q1
$1.11M Sell
58,201
-48,136
-45% -$916K 0.1% 336
2021
Q4
$2.82M Buy
106,337
+39,137
+58% +$1.04M 0.22% 167
2021
Q3
$2.76M Sell
67,200
-61,700
-48% -$2.54M 0.2% 210
2021
Q2
$7.3M Buy
128,900
+61,111
+90% +$3.46M 0.48% 9
2021
Q1
$2.85M Buy
+67,789
New +$2.85M 0.2% 208
2020
Q4
Sell
-19,279
Closed -$541K 729
2020
Q3
$541K Buy
+19,279
New +$541K 0.04% 431
2020
Q2
Sell
-14,511
Closed -$288K 702
2020
Q1
$288K Sell
14,511
-94,537
-87% -$1.88M 0.02% 484
2019
Q4
$3.23M Buy
109,048
+17,648
+19% +$523K 0.2% 146
2019
Q3
$2.08M Sell
91,400
-48
-0.1% -$1.09K 0.12% 201
2019
Q2
$2.26M Buy
91,448
+80,917
+768% +$2M 0.13% 172
2019
Q1
$257K Sell
10,531
-87,943
-89% -$2.15M 0.01% 369
2018
Q4
$2.24M Sell
98,474
-51
-0.1% -$1.16K 0.13% 183
2018
Q3
$3.14M Sell
98,525
-52,638
-35% -$1.67M 0.13% 189
2018
Q2
$5.42M Buy
151,163
+238
+0.2% +$8.53K 0.21% 155
2018
Q1
$5M Buy
+150,925
New +$5M 0.17% 165